Nature Research Round Table: Standards for Pluripotent Stem Cell Banking
Dr. Glyn Stacey, Director of the International Stem Cell Banking Initiative (ISCBI), discusses standards for pluripotent stem cell (PSC) banking with a focus on scientific challenges for PSCs, standardization of ethics, the role of stem cell biobanks, and best practices for cell therapy. This presentation and the following Q&A session were moderated by Dr. Joanne Mountford from the University of Glasgow.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Publish Date: November 01, 2019
Views: 38
Related Multimedia
-
21:35Nature Research Round Table: Regulations Around Human Induced Pluripotent Stem Cell Registration
Publish Date: November 01, 2019 Views: 25 -
13:01Nature Research Round Table: HLA Typing Considerations for Human Pluripotent Stem Cell Banking
Publish Date: November 01, 2019 Views: 20 -
33:47Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
Publish Date: November 01, 2019 Views: 166
Explore Our Products
-
Defined, serum-free cryopreservation medium for human ES and iPS cells -
cGMP, feeder-free maintenance medium for human ES and iPS cells -
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells -
Animal component-free suspension culture medium for human ES and iPS cells